Columbus Circle Capital Corp II CMIIU
10.79 USD 0.00 (+0.00%)
At closeJul 7, 2026, 4:00 PM EDT
9.94 -0.85 -7.88%
After hours · Jul 7, 4:00 PM ET
10.79 Day range 10.79
52-week range unavailable
- YTD
- +7.79%
- 1 year
- +7.79%
- Market cap
- 203.34M
- YTD return
- +7.79%
- 1-year return
- +7.79%
- Volume
- 2
- Open
- 10.95
- Previous close
- 10.79
- Day's range
- 10.79 – 10.79
No chart data for this range yet.
Key statistics
- Enterprise value
- 386.42M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 77.38
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 673.77K
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 11.53
- 200-day average
- 12.70
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
CMIIU Revenue — quarterly 0
CMIIU Net income — quarterly -15.06K
CMIIU EPS — quarterly 0.00
About Columbus Circle Capital Corp II
As of July 22, 2021, CM Life Sciences II Inc. was acquired by SomaLogic, Inc., in a reverse merger transaction. CM Life Sciences II Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
- Website
- ii.cmlifesciencesspac.com
News
Columbus Circle Capital Corp II Announces Elroy Air Was Awarded an Up to $46M Contract with U.S. Army 
Columbus Circle Capital Corp II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 27, 2026 
Columbus Circle Capital Corp. II and Cohen & Company Inc. Announce Completion of $230,000,000 Initial Public Offering 
Columbus Circle Capital Corp II Announces Pricing of $200,000,000 Initial Public Offering 
U.S. IPO Weekly Recap: Equipment Rental Rises While Crypto Company Crashes In 2-IPO Week 
SomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodies 
ARK Investment Leans Into Biotech and Telecom Holdings 
SomaLogic Customizable Protein Panels With Industry-Leading 7,000-Plex Assay Now Available 
SomaLogic Latest to Take SPAC Route to Public Markets 
CM Life Sciences II Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Pricing of Upsized $240 Million Initial Public Offering
Your note
Sign in to keep a note on CMIIU — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK Investment Management, LLC | 14.24% | 2,848,522 | 38.31M | Jun 29, 2021 |
| Price (T.Rowe) Associates Inc | 8.29% | 1,658,794 | 22.31M | Jun 29, 2021 |
| Weiss Multi-Strategy Advisers, LLC | 7.67% | 1,533,901 | 20.63M | Jun 29, 2021 |
| Perceptive Advisors Llc | 6.25% | 1,250,000 | 16.81M | Jun 29, 2021 |
| Pura Vida Investments, LLC | 5.23% | 1,045,043 | 14.06M | Jun 29, 2021 |
| Marshall Wace LLP | 5.20% | 1,039,088 | 13.98M | Jun 29, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Tr-ARK Genomic Revolution ETF | 13.70% | 2,740,375 | 32.36M | Jul 30, 2021 |
| Price (T.Rowe) New Horizons Fund | 4.14% | 828,125 | 11.14M | Jun 29, 2021 |
| Weiss Strategic Interval Fd | 2.23% | 445,441 | 5.99M | Jun 29, 2021 |
| Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I | 1.85% | 370,557 | 4.93M | May 30, 2021 |
| Morgan Stanley Inst Fund Inc-Inception Port | 1.53% | 305,714 | 4.11M | Jun 29, 2021 |
| Driehaus Event Driven Fund | 0.66% | 131,600 | 1.77M | Jun 29, 2021 |